These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 25542050

  • 21. A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
    Teethaisong Y, Hobbs G, Nakouti I, Evans K, Eumkeb G.
    Diagn Microbiol Infect Dis; 2018 May; 91(1):85-88. PubMed ID: 29422274
    [Abstract] [Full Text] [Related]

  • 22. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G, Vila J, Seral C, Castillo FJ.
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [Abstract] [Full Text] [Related]

  • 23. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
    Vlek AL, Frentz D, Haenen A, Bootsma HJ, Notermans DW, Frakking FN, de Greeff SC, Leenstra T, ISIS-AR study group.
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
    [Abstract] [Full Text] [Related]

  • 24. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS, Lee WS, Bai KJ, Lam C, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [Abstract] [Full Text] [Related]

  • 25. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
    Jean SS, Hsueh PR, Lee WS, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Lam C, Chen RJ.
    Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
    [Abstract] [Full Text] [Related]

  • 26. Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae.
    Tamma PD, Huang Y, Opene BN, Simner PJ.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6425-9. PubMed ID: 27503655
    [Abstract] [Full Text] [Related]

  • 27. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR, Frei CR, Burgess DS.
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [Abstract] [Full Text] [Related]

  • 28. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
    Huang TD, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y.
    J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
    [Abstract] [Full Text] [Related]

  • 29. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD, Bogaerts P, Berhin C, Hoebeke M, Bauraing C, Glupczynski Y, a multicentre study groupThe members of the group are listed at the end of the article..
    Euro Surveill; 2017 May 11; 22(19):. PubMed ID: 28537547
    [Abstract] [Full Text] [Related]

  • 30. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
    Cercenado E.
    Rev Esp Quimioter; 2015 Sep 11; 28 Suppl 1():8-11. PubMed ID: 26365726
    [Abstract] [Full Text] [Related]

  • 31. Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases.
    Isla A, Canut A, Arribas J, Asín-Prieto E, Rodríguez-Gascón A.
    Eur J Clin Microbiol Infect Dis; 2016 Mar 11; 35(3):511-9. PubMed ID: 26782093
    [Abstract] [Full Text] [Related]

  • 32. Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
    Caméléna F, Cointe A, Mathy V, Hobson C, Doit C, Bercot B, Decré D, Podglajen I, Dortet L, Monjault A, Bidet P, Bonacorsi S, Birgy A.
    J Clin Microbiol; 2018 Sep 11; 56(9):. PubMed ID: 29950336
    [Abstract] [Full Text] [Related]

  • 33. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á, Cantero M, Shaw E, Vergara-López S.
    Enferm Infecc Microbiol Clin; 2014 Dec 11; 32 Suppl 4():61-6. PubMed ID: 25542054
    [Abstract] [Full Text] [Related]

  • 34. Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry.
    Tadros M, Goneau L, Romaschin A, Jarvis M, Matukas L.
    PLoS One; 2018 Dec 11; 13(11):e0206842. PubMed ID: 30412608
    [Abstract] [Full Text] [Related]

  • 35. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD, Berhin C, Bogaerts P, Glupczynski Y, multicentre study group.
    J Antimicrob Chemother; 2013 Aug 11; 68(8):1832-7. PubMed ID: 23557926
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
    Liu PY, Shi ZY, Tung KC, Shyu CL, Chan KW, Liu JW, Wu ZY, Kao CC, Huang YC, Lin CF.
    J Infect Dev Ctries; 2014 Mar 13; 8(3):289-96. PubMed ID: 24619258
    [Abstract] [Full Text] [Related]

  • 38. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
    Bradford PA, Kazmierczak KM, Biedenbach DJ, Wise MG, Hackel M, Sahm DF.
    Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1385-92. PubMed ID: 26666920
    [Abstract] [Full Text] [Related]

  • 39. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
    Demir Y, Zer Y, Karaoglan I.
    Pak J Pharm Sci; 2015 May 14; 28(3 Suppl):1127-33. PubMed ID: 26051720
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.